Search

Dear Editor, Novel coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global pandemic on March 2020.1 Recalcati I et al i .2 reported cutaneous manifestations in 20.4% of COVID-19 patients. Given the overlapping features of toxic shock syndrome (TSS) and staphylococcal scalded skin syndrome (SSSS), the patients were diagnosed with COVID-19-associated exfoliative shock syndrome. (ii) COVID-19-induced rash and mucositis (CIRM) was diagnosed in one patient who developed a Stevens-Johnson syndrome (SJS)-like eruption in the absence of prior drug exposure. [Extracted from the article]